FDA Inspection 605787 — Vitalant

Vitalant — FEI 2070111

The FDA completed an inspection of Vitalant on August 19, 2009 in Santa Barbara, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 19, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Santa Barbara, CA (United States)